Literature DB >> 1316984

Organization and function of the mcrBC genes of Escherichia coli K-12.

E A Raleigh1.   

Abstract

Many natural DNA sequences are restricted in Escherichia coli K-12, not only by the classic Type I restriction system EcoK, but also by one of three modification-specific restriction systems found in K-12. The McrBC system is the best studied of these. We infer from the base composition of the mcrBC genes that they were imported from an evolutionarily distant source. The genes are located in a hypervariable cluster of restriction genes that may play a significant role in generation of species identity in enteric bacteria. Restriction activity requires the products of two genes for activity both in vivo and in vitro. The mcrB gene elaborates two protein products, only one of which is required for activity in vitro, but both of which contain a conserved amino acid sequence motif identified as a possible GTP-binding site. The mcrC gene product contains a leucine heptad repeat that could play a role in protein-protein interactions. McrBC activity in vivo and in vitro depends on the presence of modified cytosine in a specific sequence context; three different modifications are recognized. The in vitro activity of this novel multi-subunit restriction enzyme displays an absolute requirement for GTP as a cofactor.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1316984     DOI: 10.1111/j.1365-2958.1992.tb01546.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  50 in total

Review 1.  Nucleoside triphosphate-dependent restriction enzymes.

Authors:  D T Dryden; N E Murray; D N Rao
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

2.  The McrBC restriction endonuclease assembles into a ring structure in the presence of G nucleotides.

Authors:  D Panne; S A Müller; S Wirtz; A Engel; T A Bickle
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

3.  Cloning of the BssHII restriction-modification system in Escherichia coli : BssHII methyltransferase contains circularly permuted cytosine-5 methyltransferase motifs.

Authors:  S Xu; J Xiao; J Posfai; R Maunus; J Benner
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

4.  Improved efficiency for T-DNA-mediated transformation and plasmid rescue inArabidopsis thaliana.

Authors:  A Mandal; V Lång; W Orczyk; E T Palva
Journal:  Theor Appl Genet       Date:  1993-06       Impact factor: 5.699

5.  Molecular organization of intrinsic restriction and modification genes BsuM of Bacillus subtilis Marburg.

Authors:  Hideyuki Ohshima; Satoshi Matsuoka; Kei Asai; Yoshito Sadaie
Journal:  J Bacteriol       Date:  2002-01       Impact factor: 3.490

Review 6.  Linkage map of Escherichia coli K-12, edition 10: the traditional map.

Authors:  M K Berlyn
Journal:  Microbiol Mol Biol Rev       Date:  1998-09       Impact factor: 11.056

7.  The MspJI family of modification-dependent restriction endonucleases for epigenetic studies.

Authors:  Devora Cohen-Karni; Derrick Xu; Lynne Apone; Alexey Fomenkov; Zhiyi Sun; Paul J Davis; Shannon R Morey Kinney; Megumu Yamada-Mabuchi; Shuang-yong Xu; Theodore Davis; Sriharsa Pradhan; Richard J Roberts; Yu Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

8.  Determination of methylation specificity of DsaV methyltransferase by a simple biochemical method.

Authors:  J Gopal; A S Bhagwat
Journal:  Nucleic Acids Res       Date:  1995-01-11       Impact factor: 16.971

9.  Families of restriction enzymes: an analysis prompted by molecular and genetic data for type ID restriction and modification systems.

Authors:  A J Titheradge; J King; J Ryu; N E Murray
Journal:  Nucleic Acids Res       Date:  2001-10-15       Impact factor: 16.971

10.  Two genes involved in the phase-variable phi C31 resistance mechanism of Streptomyces coelicolor A3(2).

Authors:  D J Bedford; C Laity; M J Buttner
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.